Begin main content

Insulin glargine

Last Updated: September 4, 2015
Result type: Reports
Project Number: SE0451-000
Product Line: Common Drug Review

Generic Name: Insulin glargine

Brand Name: Basaglar

Manufacturer: Eli Lilly Canada Inc.

Indications: Diabetes mellitus, Type 1 & 2

Submission Type: New

Project Status: Complete

Date Recommendation Issued: April 14, 2016

Recommendation Type: List with clinical criteria and/or conditions

Tags

biosimilar pharmaceuticals, diabetes mellitus, diabetes